Page last updated: 2024-09-03

ici 89406 and 3,4-dihydroxyphenylacetic acid

ici 89406 has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

*3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA. [MeSH]

Compound Research Comparison

Studies
(ici 89406)
Trials
(ici 89406)
Recent Studies (post-2010)
(ici 89406)
Studies
(3,4-dihydroxyphenylacetic acid)
Trials
(3,4-dihydroxyphenylacetic acid)
Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid)
45125,41038591

Protein Interaction Comparison

ProteinTaxonomyici 89406 (IC50)3,4-dihydroxyphenylacetic acid (IC50)
intestinal alkaline phosphatase precursorMus musculus (house mouse)4.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goshima, Y; Misu, Y; Nakamura, S1

Other Studies

1 other study(ies) available for ici 89406 and 3,4-dihydroxyphenylacetic acid

ArticleYear
L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices.
    Japanese journal of pharmacology, 1990, Volume: 53, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic beta-Antagonists; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dopamine; Electric Stimulation; Hydrazines; Hypothalamus; In Vitro Techniques; Kinetics; Levodopa; Male; Norepinephrine; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta

1990